PGE2 stimulates the de novo conversion of Tregs from naïve CD4+ T cells (29), and Tregs expressing PGE2 receptors are preferentially recruited to factors expressed by COX-2-expressing tumor cells (30). This evidence concerns the gene PTGS2 and neoplasm.